Overview

Historically, biopharmaceutical manufacturers have had to rely on tube welders to unite small-diameter tubes (<3.2mm or <1/8”) in their bioprocesses—simply because no other option existed for closed aseptic processing. As a result, biomanufacturers have traditionally assumed tube-welding associated costs and operational challenges out of necessity. With the recent introduction of the MicroCNX® Series Connectors, biomanufacturers now have a new option of a trusted and user-friendly single-use technology.

This white paper discusses survey data comparing the comprehensive operational costs of tube welding against small volume, sterile, single-use connectors to help bioprocess teams make informed decisions about the best solution for creating their closed aseptic systems.